Hormonal Contraceptive Use and the Prevalence of Endometriotic Lesions at Different Regions within the Peritoneal Cavity

Table 3

Prevalence of women with endometriotic lesions in single regions only with and without hormonal contraceptive use.

	Ovarian, 𝑛 (%)	Peritoneal, 𝑛 (%)	RVS, 𝑛 (%)	𝑃 value
Single location cases
No hormone 𝑛 (%)	16 (39.0)	14 (34.1)	11 (26.8)	0.0347
HC 𝑛 (%)	6 (15.0)	23 (57.5)	11 (27.5)

A Chi-squared test was used to determine whether the incidence of endometriotic lesions in different locations was significantly different under HC use.